Answers are grounded in this paper and cite their sources.
Background This study aimed to systematically review and quantify the associations between clinicopathological factors and biochemical recurrence (BCR) following robot-assisted radical prostatectomy (RARP). Methods This study systematically searched PubMed, Embase, the Cochrane Library, and Web of Science for observational studies on predictors of BCR following RARP. The search was conducted up to March 20, 2026. Included studies were required to report results of multivariate analyses and provide odds ratios (OR) with their 95% confidence intervals (CI). Study quality was assessed using the Newcastle–Ottawa Scale (NOS) criteria, and data analysis was performed using Stata 15. Results A total of 16 cohort studies were ultimately included, involving 6,409 prostate cancer patients who underwent robot-assisted radical prostatectomy. The meta-analysis revealed that PSA ≥ 10 ng/ml [OR=1.97, 95% CI (1.56, 2.50)], Gleason Score of ≥8 [OR=4.22, 95% CI (2.81, 6.33)], pathological stage T3a [OR=2.34, 95% CI (1.84, 2.99)], positive surgical margin [OR=2.09, 95% CI (1.75, 2.50)], ISUP level increased [OR=2.60, 95% CI (1.90, 3.54)], positive lymph nodes [OR=2.69, 95% CI (1.66, 4.36)] were associated with an increased risk of BCR. Conclusions This meta-analysis summarizes associations between established clinicopathological factors and BCR after RARP. The findings provide a synthesis of prognostic-factor evidence but do not constitute the development or validation of a clinical prediction model. Individual recurrence probabilities, model performance, and incremental predictive value beyond existing tools were not evaluated.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: